Target Price | $43.40 |
Price | $38.71 |
Potential | 12.12% |
Number of Estimates | 15 |
15 Analysts have issued a price target Exelon 2025 . The average Exelon target price is $43.40. This is 12.12% higher than the current stock price. The highest price target is $47.00 21.42% , the lowest is $39.00 0.75% . | |
A rating was issued by 22 analysts: 7 Analysts recommend Exelon to buy, 14 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Exelon stock has an average upside potential 2025 of 12.12% . Most analysts recommend the Exelon stock at Hold. |
11 Analysts have issued a sales forecast Exelon 2024 . The average Exelon sales estimate is $21.9b . This is 4.67% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $23.0b 0.52% , the lowest is $19.9b 13.29% .
This results in the following potential growth metrics:
2023 | $21.7b | 13.89% |
---|---|---|
2024 | $21.9b | 0.60% |
2025 | $22.6b | 3.32% |
2026 | $23.3b | 3.21% |
2027 | $23.7b | 1.70% |
2028 | $24.0b | 1.45% |
9 Analysts have issued an Exelon EBITDA forecast 2024. The average Exelon EBITDA estimate is $8.3b . This is 5.30% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $8.5b 8.25% , the lowest is $7.9b 0.63% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $7.5b | 9.65% |
---|---|---|
2024 | $8.3b | 9.75% |
2025 | $8.9b | 7.35% |
2026 | $9.5b | 6.91% |
2027 | $10.4b | 9.15% |
2028 | $11.0b | 6.26% |
2023 | 34.74% | 3.72% |
---|---|---|
2024 | 37.90% | 9.10% |
2025 | 39.38% | 3.91% |
2026 | 40.79% | 3.58% |
2027 | 43.78% | 7.33% |
2028 | 45.86% | 4.75% |
6 Exelon Analysts have issued a net profit forecast 2024. The average Exelon net profit estimate is $2.5b . This is 1.23% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.5b 2.47% , the lowest is $2.5b 0.74% .
This results in the following potential growth metrics and future Net Margins:
2023 | $2.4b | 6.36% |
---|---|---|
2024 | $2.5b | 5.12% |
2025 | $2.6b | 7.16% |
2026 | $2.8b | 5.05% |
2027 | $3.0b | 6.71% |
2028 | $3.1b | 5.63% |
2023 | 10.82% | 6.60% |
---|---|---|
2024 | 11.31% | 4.49% |
2025 | 11.73% | 3.71% |
2026 | 11.94% | 1.79% |
2027 | 12.53% | 4.94% |
2028 | 13.05% | 4.15% |
6 Analysts have issued a Exelon forecast for earnings per share. The average Exelon <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $2.46 . This is 1.23% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $2.49 2.47% , the lowest is $2.45 0.82% .
This results in the following potential growth metrics and future valuations:
2023 | $2.34 | 6.36% |
---|---|---|
2024 | $2.46 | 5.13% |
2025 | $2.64 | 7.32% |
2026 | $2.77 | 4.92% |
2027 | $2.96 | 6.86% |
2028 | $3.12 | 5.41% |
Current | 15.95 | 12.02% |
---|---|---|
2024 | 15.74 | 1.32% |
2025 | 14.68 | 6.73% |
2026 | 13.98 | 4.77% |
2027 | 13.10 | 6.29% |
2028 | 12.40 | 5.34% |
Based on analysts' sales estimates for 2024, the Exelon stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 3.83 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 1.78 .
This results in the following potential growth metrics and future valuations:
Current | 3.66 | 5.18% |
---|---|---|
2024 | 3.83 | 4.77% |
2025 | 3.71 | 3.22% |
2026 | 3.60 | 3.11% |
2027 | 3.54 | 1.67% |
2028 | 3.49 | 1.43% |
Current | 1.70 | 7.98% |
---|---|---|
2024 | 1.78 | 4.90% |
2025 | 1.72 | 3.21% |
2026 | 1.67 | 3.11% |
2027 | 1.64 | 1.67% |
2028 | 1.62 | 1.43% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.